Register for streaming realtime charts, analysis tools, and prices.
Period:
Draw Mode:
| Volume | 1,096,685 |
|
|||||
| News | - | ||||||
| Day High | 3.02 | Low High |
|||||
| Day Low | 2.2501 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| ProKidney Corporation | PROK | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.37 | -13.60% | 2.35 | 13:35:24 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 2.68 | 2.2501 | 3.02 | 2.72 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 7,191 | 1,096,685 | $ 2.56 | $ 2,803,823 | - | 1.12 - 13.51 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 13:35:24 | 49 | $ 2.35 | USD |
ProKidney Corporation Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 2.18B | 235.43M | - | 0 | -35.47M | -0.15 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
ProKidney News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical PROK Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 2.32 | 3.02 | 1.97 | 2.59 | 1,152,997 | 0.03 | 1.29% |
| 1 Month | 1.67 | 3.37 | 1.4081 | 2.30 | 1,123,461 | 0.68 | 40.72% |
| 3 Months | 1.27 | 3.37 | 1.18 | 1.90 | 737,842 | 1.08 | 85.04% |
| 6 Months | 1.75 | 3.37 | 1.12 | 1.76 | 820,744 | 0.60 | 34.29% |
| 1 Year | 10.99 | 13.51 | 1.12 | 3.67 | 628,957 | -8.64 | -78.62% |
| 3 Years | 9.40 | 14.19 | 1.12 | 4.62 | 406,911 | -7.05 | -75.00% |
| 5 Years | 9.40 | 14.19 | 1.12 | 4.62 | 406,911 | -7.05 | -75.00% |
ProKidney Description
| ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's own cells isolated from the patient intended for treatment. Its lead product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's own renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. |
